Skip to main content
Digital Seminar

The New World of Psychopharmacology: Essential Updates for Mental Health Professionals


Faculty:
Kenneth Carter, PhD, ABPP
Duration:
2 Hours 04 Minutes
Copyright:
Feb 15, 2021
Product Code:
NOS096140
Media Type:
Digital Seminar
Access:
Never expires.


Description

How many of your clients are taking psychotropic medicines prescribed by other healthcare professionals? Do you always know what they’re taking. Or understand why? And if it’s working or doing more harm than good? Despite who wrote the script, it’s your responsibility to know your clients' symptoms and reactions to medications, and to coordinate their care. This session focuses on providing practical and useful information about antidepressants, anti-anxiety medications, and medication for insomnia, as well as the tools to handle the ethical decisions that surround psychopharmacology. Get to the bottom line on the most prescribed antidepressants, anti-anxiety medications, and medication for insomnia on the market today, and learn how to discuss scope of practice with your patients in order to optimize their care. The goal is for you to leave better prepared to communicate with your clients as well as the prescribers. You’ll discover: 

  • The most effective ways to help your clients taking psychotherapeutic medications 
  • Understand the research behind common medications used for the treatment of depressive disorders, anxiety disorders, and insomnia   
  • Recent advances in the medications for depressive disorders, anxiety disorders, and insomnia

CPD


CPD
- PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This online program is worth 2.25 hours CPD for points calculation by your association.

Handouts

Faculty

Kenneth Carter, PhD, ABPP's Profile

Kenneth Carter, PhD, ABPP Related seminars and products


Kenneth Carter, PhD, ABPP, is a board-certified clinical psychologist and professor of psychology at Oxford College of Emory University in Atlanta, Georgia. Dr. Carter received his MA and PhD in clinical psychology from the University of Michigan in Ann Arbor and a postdoctoral master’s degree in clinical psychology from Fairleigh Dickerson University. Dr. Carter has taught clinical psychopharmacology classes at Emory University since 2005 and has presented highly rated psychopharmacology workshops to clinicians throughout the United States since 2010. Dr. Carter has served as senior assistant research scientist in the Epidemic Intelligence Service of the Centers for Disease Control and Prevention. He has been a psychotherapist and researcher for more than 20 years during which time he has garnered awards from the National Institutes of Health, the National Heart, Lung and Blood Institute, and the University of Michigan. Dr. Carter has presented at numerous conferences and written several books and articles on introductory psychology, neuropsychology and psychopharmacology.

Speaker Disclosures:
Financial: Dr. Kenneth Carter has employment relationships with Positive Impact Health Centers and Oxford College of Emory University. He is a published author and receives royalties. Dr. Carter receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Kenneth Carter is a member of the American Psychological Association, the Association for Psychological Science, the Neuroscience Education Institute, the American Association for the Advancement of Pharmocotherapy, and the American Board of Professional Psychology.


Objectives

  1. Investigate the proper role of mental health professionals who treat clients receiving both psychotherapeutic medications and psychotherapy.   
  2. Determine the traditional medications used for the treatment of depressive disorders, anxiety disorders, and medications for insomnia.   
  3. Assess recent advances in the medications for depressive disorders, anxiety disorders, and insomnia.

Outline

  • Why (and what) you should know about psychopharmacology   
  • Questions you can expect from clients and prescribers and how to answer them   
  • Latest information and newest medications for depression, anxiety, and insomnia  

Target Audience

  • Counsellors
  • Social Workers
  • Psychologists
  • Psychotherapists
  • Therapists
  • Marriage & Family Therapists
  • Addiction Counsellors
  • Case Managers
  • Physicians
  • Nurses
  • Other Mental Health Professionals

Please wait ...

Back to Top